Telix Pharmaceuticals Limited American Depositary Shares (TLX) Competitors $16.01 +0.01 (+0.06%) (As of 05:27 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsSEC FilingsTrends TLX vs. TEVA, BGNE, UTHR, VTRS, RPRX, SMMT, GMAB, INSM, BMRN, and RDYShould you be buying Telix Pharmaceuticals Limited American Depositary Shares stock or one of its competitors? The main competitors of Telix Pharmaceuticals Limited American Depositary Shares include Teva Pharmaceutical Industries (TEVA), BeiGene (BGNE), United Therapeutics (UTHR), Viatris (VTRS), Royalty Pharma (RPRX), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Insmed (INSM), BioMarin Pharmaceutical (BMRN), and Dr. Reddy's Laboratories (RDY). These companies are all part of the "pharmaceutical preparations" industry. Telix Pharmaceuticals Limited American Depositary Shares vs. Teva Pharmaceutical Industries BeiGene United Therapeutics Viatris Royalty Pharma Summit Therapeutics Genmab A/S Insmed BioMarin Pharmaceutical Dr. Reddy's Laboratories Teva Pharmaceutical Industries (NYSE:TEVA) and Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations, community ranking and institutional ownership. Is TEVA or TLX more profitable? Telix Pharmaceuticals Limited American Depositary Shares has a net margin of 0.00% compared to Teva Pharmaceutical Industries' net margin of -5.73%. Teva Pharmaceutical Industries' return on equity of 42.92% beat Telix Pharmaceuticals Limited American Depositary Shares' return on equity.Company Net Margins Return on Equity Return on Assets Teva Pharmaceutical Industries-5.73% 42.92% 7.25% Telix Pharmaceuticals Limited American Depositary Shares N/A N/A N/A Does the MarketBeat Community believe in TEVA or TLX? Teva Pharmaceutical Industries received 1324 more outperform votes than Telix Pharmaceuticals Limited American Depositary Shares when rated by MarketBeat users. However, 100.00% of users gave Telix Pharmaceuticals Limited American Depositary Shares an outperform vote while only 67.79% of users gave Teva Pharmaceutical Industries an outperform vote. CompanyUnderperformOutperformTeva Pharmaceutical IndustriesOutperform Votes132667.79% Underperform Votes63032.21% Telix Pharmaceuticals Limited American Depositary SharesOutperform Votes2100.00% Underperform VotesNo Votes Do institutionals and insiders hold more shares of TEVA or TLX? 54.0% of Teva Pharmaceutical Industries shares are held by institutional investors. 0.6% of Teva Pharmaceutical Industries shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has better earnings and valuation, TEVA or TLX? Telix Pharmaceuticals Limited American Depositary Shares has lower revenue, but higher earnings than Teva Pharmaceutical Industries. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTeva Pharmaceutical Industries$16.77B1.43-$559M-$0.85-24.94Telix Pharmaceuticals Limited American Depositary Shares$637.08M8.41N/AN/AN/A Does the media prefer TEVA or TLX? In the previous week, Teva Pharmaceutical Industries had 17 more articles in the media than Telix Pharmaceuticals Limited American Depositary Shares. MarketBeat recorded 19 mentions for Teva Pharmaceutical Industries and 2 mentions for Telix Pharmaceuticals Limited American Depositary Shares. Telix Pharmaceuticals Limited American Depositary Shares' average media sentiment score of 0.83 beat Teva Pharmaceutical Industries' score of 0.67 indicating that Telix Pharmaceuticals Limited American Depositary Shares is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Teva Pharmaceutical Industries 12 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Telix Pharmaceuticals Limited American Depositary Shares 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TEVA or TLX? Teva Pharmaceutical Industries currently has a consensus price target of $20.88, suggesting a potential downside of 1.53%. Telix Pharmaceuticals Limited American Depositary Shares has a consensus price target of $21.00, suggesting a potential upside of 31.17%. Given Telix Pharmaceuticals Limited American Depositary Shares' stronger consensus rating and higher probable upside, analysts clearly believe Telix Pharmaceuticals Limited American Depositary Shares is more favorable than Teva Pharmaceutical Industries.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Teva Pharmaceutical Industries 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Telix Pharmaceuticals Limited American Depositary Shares 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryTeva Pharmaceutical Industries beats Telix Pharmaceuticals Limited American Depositary Shares on 8 of the 15 factors compared between the two stocks. Ad Huge AlertsUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Click here to see how this opportunity could transform your portfolio. Get Telix Pharmaceuticals Limited American Depositary Shares News Delivered to You Automatically Sign up to receive the latest news and ratings for TLX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLX vs. The Competition Export to ExcelMetricTelix Pharmaceuticals Limited American Depositary SharesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.36B$6.70B$5.02B$8.94BDividend YieldN/A3.06%4.83%4.06%P/E RatioN/A10.45133.4516.94Price / Sales8.41267.741,146.62127.75Price / CashN/A57.1640.6337.95Price / BookN/A5.194.754.71Net IncomeN/A$151.85M$118.34M$225.20M7 Day Performance1.52%-7.93%11.87%-3.77%1 Month Performance8.54%-1.49%11.93%4.45%1 Year PerformanceN/A12.15%31.40%18.66% Telix Pharmaceuticals Limited American Depositary Shares Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLXTelix Pharmaceuticals Limited American Depositary SharesN/A$16.01+0.1%$21.00+31.2%N/A$5.36B$637.08M0.00N/ANews CoveragePositive NewsTEVATeva Pharmaceutical Industries2.1787 of 5 stars$16.65+0.9%$19.67+18.1%+109.2%$18.86B$16.77B-19.7937,851Analyst ForecastOptions VolumeNews CoverageGap DownBGNEBeiGene2.6281 of 5 stars$176.52-1.6%$253.69+43.7%-2.2%$17.20B$2.46B-21.7710,600UTHRUnited Therapeutics4.6534 of 5 stars$370.95+2.5%$370.860.0%+54.1%$16.56B$2.76B16.221,168Positive NewsVTRSViatris2.273 of 5 stars$12.71+0.6%$13.67+7.5%+22.6%$15.17B$15.05B-17.0738,000News CoverageRPRXRoyalty Pharma4.6867 of 5 stars$25.17+1.3%$41.67+65.5%-8.2%$14.83B$2.36B12.8780SMMTSummit Therapeutics3.322 of 5 stars$18.21+2.1%$33.33+83.0%+625.4%$13.43B$700,000.00-63.68105GMABGenmab A/S4.2816 of 5 stars$20.14-0.1%$45.20+124.4%-35.1%$13.33B$19.84B19.582,204Short Interest ↓Gap UpHigh Trading VolumeINSMInsmed3.1178 of 5 stars$73.07+2.0%$83.67+14.5%+159.9%$13.07B$342.96M-12.91373Positive NewsBMRNBioMarin Pharmaceutical4.9763 of 5 stars$65.89-0.2%$94.20+43.0%-30.8%$12.56B$2.75B39.533,401Positive NewsRDYDr. Reddy's Laboratories2.1261 of 5 stars$14.75+2.0%$17.00+15.3%+8.6%$12.31B$299.87B22.9527,048 Related Companies and Tools Related Companies TEVA Alternatives BGNE Alternatives UTHR Alternatives VTRS Alternatives RPRX Alternatives SMMT Alternatives GMAB Alternatives INSM Alternatives BMRN Alternatives RDY Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TLX) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telix Pharmaceuticals Limited American Depositary Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Telix Pharmaceuticals Limited American Depositary Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
